The Jed Ian Taxel Foundation for Rare Cancer Research Inc (EIN 862610819) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Principal Officer

David Lord

Phone

9146714766

Tax Period

2024-01-01 to 2024-12-31

The Jed Ian Taxel Foundation for Rare Cancer Research Inc, founded in 2021, is a small nonprofit in the Medical Research sector that reported $309K in total revenue in fiscal year 2024. Revenue grew 13% year-over-year, indicating healthy expansion. Expenses of $394K exceeded revenue, resulting in a 27% operating deficit.

Mission

To inspire and empower scientific breakthroughs, clinical trials and improved treatments which change lives and enable better outcomes for rare cancer patients and their families.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $245,662

Program Service Revenue $0

Investment Income $10,062

Other Revenue $53,376

TOTAL REVENUE $309,100

Expense Breakdown

Grants Paid $0

Salaries & Benefits $40,000

Fundraising Expenses $53,449

Program Expenses $272,024

Other Expenses $353,892

TOTAL EXPENSES $393,892

Year-over-Year Comparison

	2024	2023	Change
Revenue	$309,100	$273,837	+0.1%
Expenses	$393,892	$288,471	+0.4%
Net Income	$-84,792	$-14,634	+4.8%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$40,000

Total Directors

$40,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Harmony Knutsen	President/CEO	40.00	Officer Director	$40,000	$0	$40,000
Mark Taxel	Chair	30.00	Officer Director	$0	$0	$0
Alex Wolin	Director	0.50	Director	$0	$0	$0
David Lord	Treasurer and COO/CFO	0.50	Officer Director	$0	$0	$0
Deborah Bhatt	Director	0.50	Director	$0	$0	$0
Alexander Carey	Director	0.50	Director	$0	$0	$0
Benjamin Geyerhahn	Director	0.50	Director	$0	$0	$0
Fred Kirschner	Director	0.50	Director	$0	$0	$0
Mike McCurdy	Director	0.50	Director	$0	$0	$0
Michael Rolnick	Director	0.50	Director	$0	$0	$0
Laurie Sheinman	Director	0.50	Director	$0	$0	$0
Nelson Taxel	Director	0.50	Director	$0	$0	$0
Samantha Silver	Vice Pres/Secretary	0.50	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	No data	No data	No data	No data
2024	$309,100	$393,892	$148,730	$-84,792
2023	$273,837	$288,471	$239,577	$-14,634
2022	$361,490	$430,447	$259,183	$-68,957
2021	$362,690	$79,844	$287,846	$282,846
2021	$362,689	$74,844	$287,845	$287,845

The Jed Ian Taxel Foundation for Rare Cancer Research Inc